ISSN:

Journal Home

Pilot and Feasibility Studies Q2 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pilot and Feasibility Studies is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 34. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 1790 €. The scope of the journal is focused on clinical trials, medical evidence, biomedicine. It has an SJR impact factor of 0,672 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,672.

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2)

Price

1790 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,672

SJR Impact factor

34

H Index

151

Total Docs (Last Year)

665

Total Docs (3 years)

7331

Total Refs

1263

Total Cites (3 years)

661

Citable Docs (3 years)

1.74

Cites/Doc (2 years)

48.55

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical and Translational Oncology Q2
Neuro-Oncology Practice Q2
Revista de Saude Publica Q2
Human Vaccines and Immunotherapeutics Q2
British Journal of Nutrition Q2

Compare this journals

Aims and Scope

Clinical trials Medical evidence Biomedicine